Search results
AbbVie (NYSE:ABBV) Given New $190.00 Price Target at Piper Sandler
ETF DAILY NEWS· 5 days agoAbbVie (NYSE:ABBV – Get Free Report) had its price objective boosted by research analysts at Piper Sandler from $185.00 to $190.00 in a research note issued on Tuesday, Benzinga reports. Piper ...
Johnson & Johnson submits application to U.S. FDA seeking approval of TREMFYA® (guselkumab) for the...
Morningstar· 3 days agoJohnson & Johnson (NYSE: JNJ) today announced the submission of a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) seeking approval of TREMFYA ...
U.S. FDA Approves SKYRIZI® (risankizumab-rzaa) for Ulcerative Colitis, Expanding AbbVie's Portfolio...
Morningstar· 5 days agoApproval supported by two Phase 3 clinical trials that evaluated SKYRIZI® for the treatment of moderate to severe ulcerative colitis: a 12-week induction study, INSPIRE,1 and a 52-week maintenance study, COMMAND2Data showed that clinical remission,
JD Supra: AbbVie Files Notice of Data Breach Impacting the Health Information of Tens of Thousands...
JD Supra· 20 hours agoOn May 22, 2024, AbbVie, Inc. filed a notice of data breach with the Attorney General of Texas after discovering that confidential information that had been entrusted to the company was subject ...
Amgen Inc. (NASDAQ:AMGN) Sees Significant Drop in Short Interest
ETF DAILY NEWS· 6 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) was the recipient of a large decrease in short interest in May. As of May 31st, there was short interest totalling 9,050,000 shares, a decrease of ...
Bath Savings Trust Co Acquires 196 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 3 days agoBath Savings Trust Co increased its holdings in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 1.0% during the 1st quarter, according to its most recent Form 13F filing with the Securities ...
Gerber LLC Makes New $342,000 Investment in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 6 days agoGerber LLC bought a new stake in Amgen Inc. (NASDAQ:AMGN – Free Report) during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission ...
AbbVie stock price forecast: $200 on the cards? | Invezz
Invezz· 3 days agoThis approval is a significant milestone, making Skyrizi now available for four different conditions in the U.S., including psoriatic arthritis, plaque psoriasis& ...
AbbVie Inc. (NYSE:ABBV) Shares Bought by First Financial Bank Trust Division
ETF DAILY NEWS· 4 days agoFirst Financial Bank Trust Division boosted its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 967.2% during the 1st quarter, according to the company in its most recent disclosure ...
AbbVie Inc. (NYSE:ABBV) Shares Sold by Alaska Permanent Fund Corp
ETF DAILY NEWS· 2 days agoAlaska Permanent Fund Corp lowered its stake in AbbVie Inc. (NYSE:ABBV – Free Report) by 1.8% during the first quarter, according to its most recent 13F filing with the Securities and Exchange ...